COMMUNIQUÉS West-GlobeNewswire

Neovacs announces two appointments to its executive committee
20/02/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES TWO APPOINTMENTS TO ITS EXECUTIVE COMMITTEE Vincent Serra, PhD – Chief Scientific Officer Valerie Salentey, Pharm D - Head of Regulatory Affairs Paris [...]
Néovacs annonce deux nominations au sein de son comité exécutif
20/02/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE DEUX NOMINATIONS AU SEIN DE SON COMITÉ EXÉCUTIF Vincent Serra, PhD - Directeur Scientifique (CSO) Valérie Salentey, PharmD - Responsable [...]
Canntab Provides Corporate Update
20/02/2019
Moving into FSD Pharma and FSD Processing License Mackie Research Extension Director Estate Planning Initiative OTCQB under symbol CTABF TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL [...]
Vigil Reports Third Quarter Results
20/02/2019
VICTORIA, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-VEN: VGL) announces the results of operations for the quarter ending December 31, 2018. Developments in the [...]
MacroGenics Announces Date of Fourth Quarter and Full Year 2018 Financial Results Conference Call
20/02/2019
ROCKVILLE, MD, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Chembio Diagnostics to Participate in the BTIG Medical Technology, Life Science and Diagnostic Tools Conference
20/02/2019
MEDFORD, N.Y., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the Company plans to participate in [...]
Management Cease Trade Order Update
20/02/2019
HALIFAX, Nova Scotia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives
19/02/2019
SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that it has decided to discontinue the Phase 2 clinical trial of VL‑2397 that was initiated in the first quarter of 2018. The [...]
2019 Budget Focuses on Savings for Individuals and Families
19/02/2019
VICTORIA, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The budget presented today by the B.C. government is strongly focused on reducing costs for B.C. families, a move which will be welcomed individually by [...]
REVA Announces Voluntary Suspension of Trading
19/02/2019
SAN DIEGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 20 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating [...]
Nashville Business Leader Acquires Integrative Life Center
19/02/2019
Former Premier Parking CEO, Ryan Chapman, plans to broaden services of Nashville-based behavioral health care provider NASHVILLE, Tenn., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Ryan Chapman, who grew and sold a nationwide [...]
Sienna Senior Living Inc. Reports 2018 Fourth Quarter Financial Results
19/02/2019
MARKHAM, Ontario, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three months and year ended December 31, 2018. The [...]
Lifeline Biotechnologies, Inc. Updates Current Shareholders and the Public
19/02/2019
Reno, Nevada, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- We are pleased to share current information and developments with our stakeholders and the public, February 19, 2019. Regarding Lifeline’s investment [...]
SeaSpine Appoints Kim Commins-Tzoumakas and Renee Gaeta to its Board of Directors
19/02/2019
CARLSBAD, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Digirad Corporation to Release 2018 Fourth Quarter Financial Results on March 1, 2019
19/02/2019
SUWANEE, Ga., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq: DRAD) will release financial results for its fourth quarter ended December 31, 2018 before the market opens on Friday, March 1, 2019. A [...]
Oxford Immunotec Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 11, 2019
19/02/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to [...]
Spring Bank Pharmaceuticals Appoints Atif Abbas, M.D., as Vice President, Head of Oncology & Immunology Clinical Development
19/02/2019
HOPKINTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019
19/02/2019
WESTLAKE VILLAGE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019 and its management will [...]
BeiGene Initiates Global Phase 2 Trial of Zanubrutinib in Patients with Relapsed or Refractory Marginal Zone Lymphoma
19/02/2019
CAMBRIDGE, Mass. and BEIJING, China, Feb. 19, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Pages